David Einhorn 23and Me Holding Co. Transaction History

Greenlight Capital Inc

  • $1.97 Billion
  • Q4 2023

Shares

3 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2022

Aug 15, 2022
SELL
$2.19 - $3.98 $109,500 - $199,000
-50,000 Reduced 67.94%
23,591 $59,000
Q1 2022

May 16, 2022
SELL
$3.28 - $7.12 $80,461 - $174,660
-24,531 Reduced 25.0%
73,591 $282,000
Q4 2021

Feb 14, 2022
BUY
$6.55 - $13.25 $642,699 - $1.3 Million
98,122 New
98,122 $653,000

Others Institutions Holding ME

# of Institutions
116
Shares Held
82.5M
Call Options Held
404K
Put Options Held
292K
View Full List

About 23andMe Holding Co.

ME Quotes by TradingView
  • Ticker ME
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Diagnostics & Research
  • Shares Outstandng 259,768,000
  • Market Cap $795M
  • Description
  • 23andMe Holding Co. operates as a consumer genetics testing company. It operates through two segments, Consumer & Research Services and Therapeutics. The Consumer & Research Services segment provides a suite of genetic reports, including information on customers' genetic ancestral origins, personal genetic health risks, and chances of pa...
More about ME
Track David Einhorn's Portfolio

Track David Einhorn Portfolio

Follow David Einhorn (Greenlight Capital Inc) and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Greenlight Capital Inc, based on Form 13F filings with the SEC.

News

Stay updated on Greenlight Capital Inc and David Einhorn with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email